Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$576000.0.

  • Caribou Biosciences' Other Working Capital Changes fell 11233.4% to -$576000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 16637.9%. This contributed to the annual value of $3.9 million for FY2024, which is 12322.49% up from last year.
  • Per Caribou Biosciences' latest filing, its Other Working Capital Changes stood at -$576000.0 for Q3 2025, which was down 11233.4% from -$900000.0 recorded in Q2 2025.
  • Caribou Biosciences' Other Working Capital Changes' 5-year high stood at $30.0 million during Q1 2021, with a 5-year trough of -$21.6 million in Q3 2023.
  • In the last 5 years, Caribou Biosciences' Other Working Capital Changes had a median value of -$807000.0 in 2022 and averaged $490157.9.
  • Within the past 5 years, the most significant YoY rise in Caribou Biosciences' Other Working Capital Changes was 28698.88% (2023), while the steepest drop was 257261.46% (2023).
  • Caribou Biosciences' Other Working Capital Changes (Quarter) stood at -$1.0 million in 2021, then plummeted by 51.84% to -$1.6 million in 2022, then soared by 61.33% to -$606000.0 in 2023, then surged by 228.71% to $780000.0 in 2024, then tumbled by 173.85% to -$576000.0 in 2025.
  • Its last three reported values are -$576000.0 in Q3 2025, -$900000.0 for Q2 2025, and -$996000.0 during Q1 2025.